Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120245) titled 'Multimodal Omics Analysis of Exhaled Breath Condensate and Its Application in Lung Cancer Diagnosis: A Prospective, Multicenter Study' on March 11.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Lung cancer
Intervention:
Gold Standard:Diagnosis of lung cancer: Histopathological examination after tumor puncture or surgical resection confirms lung cancer.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-21
Target Sample Size: Target condition:250;Difficult condition...